Mutations of p53 in thyroid carcinoma with an insular component

被引:45
|
作者
Takeuchi, Y [1 ]
Daa, T
Kashima, K
Yokoyama, S
Nakayama, I
Noguchi, S
机构
[1] Oita Med Univ, Dept Pathol, Hasama, Oita 8795593, Japan
[2] Noguchi Thyroid Clin & Hosp Fdn, Beppu, Oita, Japan
关键词
D O I
10.1089/thy.1999.9.377
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thyroid carcinoma with an insular component (TCIC) is considered noteworthy in view of its peculiar histopathological features and clinicopathological behavior. The purpose of the present study was to clarify the rate of mutation in the p53 gene in TCIC as compared with rates in papillary and follicular carcinomas of the thyroid. Formalin-fixed and paraffin-embedded blocks of tissue from 46 cases of TCIC were analyzed. DNA was extracted from tissues and exons 5 through 8 of the p53 gene were amphfied by the polymerase chain reaction. Mutations were detected by analysis of single-strand conformation polymorphism. Of the 46 cases of TCIC, 6 had a mutation in exon 5, 2 in exon 7, and 5 in exon 8, while 1 case had mutations in all exons examined. The mutation rate of the p53 gene in TCIC was 38%. Immunostaining revealed overexpression of p53 in nuclei that were mainly in areas of the insular component rather than in surrounding areas of well-differentiated carcinoma. The frequency of positive immunostaining in TCIC was 53%. Considering that TCIC is intermediate between papillary plus follicular carcinoma and anaplastic carcinoma in terms of survival and the rate of mutation of the p53 gene, we can speculate that mutation in the p53 gene might be associated with the insular component and might play an important role in the clinicopathological behavior of thyroid carcinoma.
引用
收藏
页码:377 / 381
页数:5
相关论文
共 50 条
  • [11] P53 MUTATIONS IN ALL STAGES OF THYROID CARCINOMAS
    ZOU, MJ
    SHI, YF
    FARID, NR
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (04): : 1054 - 1058
  • [12] ANALYSIS OF P53 GENE-MUTATIONS AND P53 NUCLEAR ACCUMULATION IN THYROID NEOPLASIA
    GHOSSEIN, R
    ROSAI, J
    LABORATORY INVESTIGATION, 1995, 72 (01) : A53 - A53
  • [13] An abundance of p53 null mutations in ovarian carcinoma
    Skilling, JS
    Sood, A
    Niemann, T
    Lager, DJ
    Buller, RE
    ONCOGENE, 1996, 13 (01) : 117 - 123
  • [14] An analysis of the p53 gene mutations in hepatocellular carcinoma
    Sugo, H
    Futagawa, S
    Beppu, T
    Fukasawa, M
    Kojima, K
    Takamori, S
    Yoshimoto, J
    Iwata, T
    XV WORLD CONGRESS OF COLLEGIUM INTERNATIONALE CHIRURGIAE DIGESTIVAE (CICD), 1996, : 775 - 778
  • [15] p53 mutations and expression in breast carcinoma in situ
    Lukas, J
    Niu, N
    Press, MF
    AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (01): : 183 - 191
  • [16] p53 mutations in hepatocellular carcinoma patients in Egypt
    El-Kafrawy, SA
    Abdel-Hamid, M
    El-Daly, M
    Nada, O
    Ismail, A
    Ezzat, S
    Abdel-Latif, S
    Abdel-Hamid, A
    Shields, PG
    Loffredo, C
    INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH, 2005, 208 (04) : 263 - 270
  • [17] Prognostic value of p53 mutations in rectal carcinoma
    Rebischung, C
    Gérard, JP
    Gayet, J
    Thomas, G
    Hamelin, R
    Laurent-Puig, P
    INTERNATIONAL JOURNAL OF CANCER, 2002, 100 (02) : 131 - 135
  • [18] Mutations of p53 gene in gastric carcinoma in Taiwan
    Wang, JY
    Lin, SR
    Hsieh, JS
    Hsu, CH
    Huang, YS
    Huang, TJ
    ANTICANCER RESEARCH, 2001, 21 (1B) : 513 - 520
  • [19] p53 Mutations in Carcinoma of the Esophagus and Gastroesophageal Junction
    Sengpiel, C.
    Koenig, I. R.
    Rades, D.
    Noack, F.
    Duchrow, M.
    Schild, S. E.
    Ludwig, D.
    Homann, N.
    CANCER INVESTIGATION, 2009, 27 (01) : 96 - 104
  • [20] p53 gene mutations in primary bladder carcinoma
    delMuro, XG
    Torregrosa, A
    Verdu, M
    Condom, E
    Munoz, J
    Vigues, F
    Fabra, A
    Germa, JR
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 130 - 130